Effectiveness of Qualia NAD+ Supplementation on NAD Levels

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2025
The current study is designed as a randomized double-blind placebo-controlled parallel trial. It aims to investigate the efficacy of Qualia NAD+ on intracellular NAD levels in blood samples (primary outcomes) and health-related quality of life (secondary outcomes) in an adult population experiencing moderate to severe joint pain between ages of 40 and 65 years.
Epistemonikos ID: 37cf925737e30eecc4ce6932363f54b6807d2e84
First added on: Mar 01, 2025